Last updated: September 1, 2023
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hearing Aid
Treatment
Standard Fitting
Standard fitting+ ABF
Anatomy-based fitting (ABF)
Clinical Study ID
NCT05360212
PI-6128
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years
- Post-lingual onset of severe to profound sensory-neural hearing loss in the implantedear(s)
- Post-OP CT scan of the CI electrode available
- Subject implanted with MED-EL cochlear implant(s)
- Subjects received a Flex28 or FlexSoft electrode
- Subject planned to receive a SONNET 2 /RONDO3 audio processor on the newly implantedside
- Audio processor not yet activated on the newly implanted side
- The most apical active electrode contact has to be inserted at least 450°
- Minimum of 10 active channels can be activated
- Fluent in Spanish
- Signed and dated ICF before the start of any study-specific procedure Specific inclusion criteria for the possible study groups • Bilateral CI users: BilateralCI implantation SONNET 2/RONDO3 audio processor on the first ear implanted
- 40% speech recognition a monosyllabic word Test in quiet at 65 dB SPL (last timetested) on the already implanted side
- 40% speech recognition in a sentence test in noise (10 dB SNR) on the alreadyimplanted side First activation of the already implanted side between 3 and 12 monthsprior to study inclusion • Unilateral CI users: Unilateral CI implantation CI user with contralateral hearing ≥ 60 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) • SSD CI users: Unilateral CI implantation CI user with contralateral hearing ≤30 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) Interaural threshold gap ≥40 dB • Bimodal CI users: Unilateral CI implantation Contralateral ear adequately fittedwith a hearing aid CI user with contralateral hearing ≥30 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) CI user with contralateral hearing ≤55 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) Interaural threshold gap ≥15 dB
Exclusion
Exclusion Criteria:
- Lack of compliance with any inclusion criteria
- EAS user (user of an EAS audio processor)
- Implanted with C40+, C40X and C40C
- Implanted with an ABI or Split electrode array
- Known allergic reactions to components of the investigational medical device
- Anything that, in the opinion of the Investigator, would place the subject atincreased risk or preclude the subject's full compliance with or completion of thestudy
Study Design
Total Participants: 30
Treatment Group(s): 3
Primary Treatment: Standard Fitting
Phase:
Study Start date:
March 11, 2022
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Hospital Universitario de La Paz
Madrid, 28046
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.